Sarah Lowndes

2.0k total citations
10 papers, 455 citations indexed

About

Sarah Lowndes is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Sarah Lowndes has authored 10 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology and Allergy. Recurrent topics in Sarah Lowndes's work include Radiopharmaceutical Chemistry and Applications (3 papers), Metal complexes synthesis and properties (3 papers) and Cell Adhesion Molecules Research (3 papers). Sarah Lowndes is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Metal complexes synthesis and properties (3 papers) and Cell Adhesion Molecules Research (3 papers). Sarah Lowndes collaborates with scholars based in United Kingdom and United States. Sarah Lowndes's co-authors include Adrian L. Harris, G.M. Mead, Andrew Lister, Anthony Timms, Shijie Cai, Andrew P. Mazar, Helen Sheldon, Steven D. Reich, Mark R. Middleton and Jennifer M. Taylor and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Sarah Lowndes

10 papers receiving 446 citations

Peers

Sarah Lowndes
Zin Myint United States
Joshua Prey United States
Baikuntha Aryal United States
Chan H. Park United States
S Clatworthy Australia
Zin Myint United States
Sarah Lowndes
Citations per year, relative to Sarah Lowndes Sarah Lowndes (= 1×) peers Zin Myint

Countries citing papers authored by Sarah Lowndes

Since Specialization
Citations

This map shows the geographic impact of Sarah Lowndes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Lowndes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Lowndes more than expected).

Fields of papers citing papers by Sarah Lowndes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Lowndes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Lowndes. The network helps show where Sarah Lowndes may publish in the future.

Co-authorship network of co-authors of Sarah Lowndes

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Lowndes. A scholar is included among the top collaborators of Sarah Lowndes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Lowndes. Sarah Lowndes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Arnold, David, Anna Morley, Paul White, et al.. (2015). The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. British Journal of Cancer. 112(7). 1183–1189. 21 indexed citations
2.
Hooper, Clare, Iain Lyburn, M. I. Darby, et al.. (2015). The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. British Journal of Cancer. 112(7). 1175–1182. 44 indexed citations
3.
Lowndes, Sarah, Ruth Asher, & Mark R. Middleton. (2010). Thyrotoxicosis With Pegylated Interferon Alfa-2b. Archives of Dermatology. 146(11). 1273–5. 2 indexed citations
4.
Lowndes, Sarah, Helen Sheldon, Shijie Cai, Jennifer M. Taylor, & Adrian L. Harris. (2009). Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvascular Research. 77(3). 314–326. 34 indexed citations
5.
Lowndes, Sarah, Anthony Timms, Nita Fisher, et al.. (2008). Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 14(22). 7526–7534. 82 indexed citations
6.
Doñate, Fernando, Sarah Lowndes, J. Juárez, et al.. (2006). 132 POSTER Translation of in vitro markers of the anti-angiogenic and anti-tumor activity of the SOD1 inhibitor ATN-224 to clinical trials. European Journal of Cancer Supplements. 4(12). 43–43. 1 indexed citations
7.
Lowndes, Sarah, Anthony Timms, Mark R. Middleton, et al.. (2006). Phase I study of ATN-224 in patients (pts) with advanced solid tumours. Journal of Clinical Oncology. 24(18_suppl). 2065–2065. 2 indexed citations
8.
Lowndes, Sarah & Adrian L. Harris. (2005). The Role of Copper in Tumour Angiogenesis. Journal of Mammary Gland Biology and Neoplasia. 10(4). 299–310. 153 indexed citations
9.
Lowndes, Sarah & Adrian L. Harris. (2004). Copper Chelation as an Antiangiogenic Therapy. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14(11). 529–540. 37 indexed citations
10.
Lowndes, Sarah, et al.. (2002). Stevens–Johnson syndrome after treatment with rituximab. Annals of Oncology. 13(12). 1948–1950. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026